Cytosorbents (CTSO) Cash & Equivalents Growth (1y) (2011 - 2026)
Powered by 
Analysis
Cytosorbents (CTSO) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -26.57% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -19.91% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 32.84% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 42.78% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 0.94% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -11.19% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -3.76% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -4.66% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 72.43% |
| 10 | Cytosorbents | 20.00 Mn | 15.59 Mn | 7.05 Mn | -56.75% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -56.75% |
| Mar 31, 2026 | -63.29% |
| Dec 31, 2025 | -36.00% |
| Sep 30, 2025 | 15.94% |
| Jun 30, 2025 | 20.63% |
| Mar 31, 2025 | 52.29% |
| Dec 31, 2024 | -30.90% |
| Sep 30, 2024 | -22.62% |
| Jun 30, 2024 | -35.92% |
| Mar 31, 2024 | -54.81% |
| Dec 31, 2023 | -36.19% |
| Sep 30, 2023 | -62.75% |
| Jun 30, 2023 | -56.24% |
| Mar 31, 2023 | -55.72% |
| Dec 31, 2022 | -57.53% |
| Sep 30, 2022 | -63.06% |
| Jun 30, 2022 | -54.02% |
| Mar 31, 2022 | -37.16% |
| Dec 31, 2021 | -27.00% |
| Sep 30, 2021 | -30.62% |